Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study.
Saved in:
| Title: | Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study. |
|---|---|
| Authors: | Cayla S; Immuno-Hématologie, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France., Karlin L; Hématologie Clinique, Centre Hospitalier Universitaire, Lyon Sud, Pierre-Bénite, France., Lambert J; Département de Biostatistique et Information Médicale, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France., Lazareth A; Hématologie Clinique, Centre Hospitalier Universitaire, Lyon Sud, Pierre-Bénite, France., Talbot A; Immuno-Hématologie, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM U1342, Paris, France., Mohty M; Service d'Hématologie Cliniue et de Thérapie Cellulaire, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France., Malard F; Service d'Hématologie Cliniue et de Thérapie Cellulaire, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France., Petillon MO; Département de Recherche Clinique, Moniteur Médical, Intergrouge Francophone du Myélome, Lille, France., Manier S; Hématologie Clinique, Centre Hospitalier Universitaire de Lille, Uni Lille, INSERM U1286, Lille, France., Yakoub-Agha I; Hématologie Clinique, Centre Hospitalier Universitaire de Lille, Uni Lille, INSERM U1286, Lille, France., Caillot D; Hématologie Clinique, Centre Hospitalier Universitaire de Dijon, Dijon, France.; Hématologie, Institut Cancerologie Bourgogne, Dijon, France., Lafon I; Hématologie, Institut Cancerologie Bourgogne, Dijon, France., Leleu X; Service Hématologie et Thérapies Cellulaires, Centre Hospitalier Universitaire La Milétrie, Poitiers, France., Moya N; Service Hématologie et Thérapies Cellulaires, Centre Hospitalier Universitaire La Milétrie, Poitiers, France., Royer B; Immuno-Hématologie, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM U1342, Paris, France., Schiano De Colella JM; Hématologie, Institut Paoli-Calmettes, Marseille, France., Brisou G; Hématologie, Institut Paoli-Calmettes, Marseille, France., Touzeau C; Service d'hématologie Clinique, Centre Hospitalier Universitaire Hôtel-Dieu, Nantes, France., Perrot A; Hematology Department, Centre de Recherche Clinique de Thérapie Cellulaire, University Hospital Oncopole, Toulouse, France., Bories P; Hematology Department, Centre de Recherche Clinique de Thérapie Cellulaire, University Hospital Oncopole, Toulouse, France., Vincent L; Département d'hématologie Clinique, Hôpital Saint Eloi, Centre Hospitalier Universitaire de Montpellier, Montpellier, France., Guedon H; Département d'hématologie Clinique, Hôpital Saint Eloi, Centre Hospitalier Universitaire de Montpellier, Montpellier, France., Decaux O; Service d'hématologie Clinique, Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Rennes, France., Ferment B; Immuno-Hématologie, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM U1342, Paris, France., Houot R; Service d'hématologie Clinique, Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Rennes, France., Le Gouill S; Onco-Hematologie, Institut Curie, Paris, France., Bigot N; Département de Biostatistique et Information Médicale, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France., Facon T; Hématologie Clinique, Centre Hospitalier Universitaire de Lille, Uni Lille, INSERM U1286, Lille, France., Corre J; Génétique du Myélome, Institut Universitaire de Recherche et de Thérapie Cellulaire, Oncopole, Toulouse, France., Avet-Loiseau H; Génétique du Myélome, Institut Universitaire de Recherche et de Thérapie Cellulaire, Oncopole, Toulouse, France., Moreau P; Service d'hématologie Clinique, Centre Hospitalier Universitaire Hôtel-Dieu, Nantes, France., Arnulf B; Immuno-Hématologie, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM U1342, Paris, France. |
| Source: | Blood advances [Blood Adv] 2026 Feb 24; Vol. 10 (4), pp. 1324-1333. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40966637 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cayla+S%22">Cayla S</searchLink>; Immuno-Hématologie, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Karlin+L%22">Karlin L</searchLink>; Hématologie Clinique, Centre Hospitalier Universitaire, Lyon Sud, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Lambert+J%22">Lambert J</searchLink>; Département de Biostatistique et Information Médicale, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lazareth+A%22">Lazareth A</searchLink>; Hématologie Clinique, Centre Hospitalier Universitaire, Lyon Sud, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Talbot+A%22">Talbot A</searchLink>; Immuno-Hématologie, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM U1342, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mohty+M%22">Mohty M</searchLink>; Service d'Hématologie Cliniue et de Thérapie Cellulaire, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Malard+F%22">Malard F</searchLink>; Service d'Hématologie Cliniue et de Thérapie Cellulaire, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Petillon+MO%22">Petillon MO</searchLink>; Département de Recherche Clinique, Moniteur Médical, Intergrouge Francophone du Myélome, Lille, France.<br /><searchLink fieldCode="AU" term="%22Manier+S%22">Manier S</searchLink>; Hématologie Clinique, Centre Hospitalier Universitaire de Lille, Uni Lille, INSERM U1286, Lille, France.<br /><searchLink fieldCode="AU" term="%22Yakoub-Agha+I%22">Yakoub-Agha I</searchLink>; Hématologie Clinique, Centre Hospitalier Universitaire de Lille, Uni Lille, INSERM U1286, Lille, France.<br /><searchLink fieldCode="AU" term="%22Caillot+D%22">Caillot D</searchLink>; Hématologie Clinique, Centre Hospitalier Universitaire de Dijon, Dijon, France.; Hématologie, Institut Cancerologie Bourgogne, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Lafon+I%22">Lafon I</searchLink>; Hématologie, Institut Cancerologie Bourgogne, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; Service Hématologie et Thérapies Cellulaires, Centre Hospitalier Universitaire La Milétrie, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Moya+N%22">Moya N</searchLink>; Service Hématologie et Thérapies Cellulaires, Centre Hospitalier Universitaire La Milétrie, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Royer+B%22">Royer B</searchLink>; Immuno-Hématologie, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM U1342, Paris, France.<br /><searchLink fieldCode="AU" term="%22Schiano+De+Colella+JM%22">Schiano De Colella JM</searchLink>; Hématologie, Institut Paoli-Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Brisou+G%22">Brisou G</searchLink>; Hématologie, Institut Paoli-Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Touzeau+C%22">Touzeau C</searchLink>; Service d'hématologie Clinique, Centre Hospitalier Universitaire Hôtel-Dieu, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Perrot+A%22">Perrot A</searchLink>; Hematology Department, Centre de Recherche Clinique de Thérapie Cellulaire, University Hospital Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Bories+P%22">Bories P</searchLink>; Hematology Department, Centre de Recherche Clinique de Thérapie Cellulaire, University Hospital Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Vincent+L%22">Vincent L</searchLink>; Département d'hématologie Clinique, Hôpital Saint Eloi, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Guedon+H%22">Guedon H</searchLink>; Département d'hématologie Clinique, Hôpital Saint Eloi, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Decaux+O%22">Decaux O</searchLink>; Service d'hématologie Clinique, Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Ferment+B%22">Ferment B</searchLink>; Immuno-Hématologie, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM U1342, Paris, France.<br /><searchLink fieldCode="AU" term="%22Houot+R%22">Houot R</searchLink>; Service d'hématologie Clinique, Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Le+Gouill+S%22">Le Gouill S</searchLink>; Onco-Hematologie, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bigot+N%22">Bigot N</searchLink>; Département de Biostatistique et Information Médicale, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Facon+T%22">Facon T</searchLink>; Hématologie Clinique, Centre Hospitalier Universitaire de Lille, Uni Lille, INSERM U1286, Lille, France.<br /><searchLink fieldCode="AU" term="%22Corre+J%22">Corre J</searchLink>; Génétique du Myélome, Institut Universitaire de Recherche et de Thérapie Cellulaire, Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Avet-Loiseau+H%22">Avet-Loiseau H</searchLink>; Génétique du Myélome, Institut Universitaire de Recherche et de Thérapie Cellulaire, Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Moreau+P%22">Moreau P</searchLink>; Service d'hématologie Clinique, Centre Hospitalier Universitaire Hôtel-Dieu, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Arnulf+B%22">Arnulf B</searchLink>; Immuno-Hématologie, Hôpital Saint-Louis Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM U1342, Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Feb 24; Vol. 10 (4), pp. 1324-1333. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40966637 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2025017597 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1324 Titles: – TitleFull: Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cayla S – PersonEntity: Name: NameFull: Karlin L – PersonEntity: Name: NameFull: Lambert J – PersonEntity: Name: NameFull: Lazareth A – PersonEntity: Name: NameFull: Talbot A – PersonEntity: Name: NameFull: Mohty M – PersonEntity: Name: NameFull: Malard F – PersonEntity: Name: NameFull: Petillon MO – PersonEntity: Name: NameFull: Manier S – PersonEntity: Name: NameFull: Yakoub-Agha I – PersonEntity: Name: NameFull: Caillot D – PersonEntity: Name: NameFull: Lafon I – PersonEntity: Name: NameFull: Leleu X – PersonEntity: Name: NameFull: Moya N – PersonEntity: Name: NameFull: Royer B – PersonEntity: Name: NameFull: Schiano De Colella JM – PersonEntity: Name: NameFull: Brisou G – PersonEntity: Name: NameFull: Touzeau C – PersonEntity: Name: NameFull: Perrot A – PersonEntity: Name: NameFull: Bories P – PersonEntity: Name: NameFull: Vincent L – PersonEntity: Name: NameFull: Guedon H – PersonEntity: Name: NameFull: Decaux O – PersonEntity: Name: NameFull: Ferment B – PersonEntity: Name: NameFull: Houot R – PersonEntity: Name: NameFull: Le Gouill S – PersonEntity: Name: NameFull: Bigot N – PersonEntity: Name: NameFull: Facon T – PersonEntity: Name: NameFull: Corre J – PersonEntity: Name: NameFull: Avet-Loiseau H – PersonEntity: Name: NameFull: Moreau P – PersonEntity: Name: NameFull: Arnulf B IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 02 Text: 2026 Feb 24 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 10 – Type: issue Value: 4 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |